Abstract
Immunoglobulins (Ig) or antibodies (Ab) are the key functional units of the humoral immune system. Antibody molecules have a highly specialized structure that can mediate biological response upon specifically binding to an antigen. This chapter introduces readers to the chemical structure of antibodies, with specific focus on the structure of immunoglobulin G (IgG). The chapter also highlights functionally important IgG domains and their susceptibility to chemical degradation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADCC:
-
Antibody-dependent cellular cytotoxicity
- CDC:
-
Complement-dependent cytotoxicity
- CDR:
-
Complementarity-determining region
- CH :
-
Constant heavy chain
- CL :
-
Constant light chain
- Fab:
-
Antigen binding fragment
- Fc:
-
Fragment crystallizable
- Ig:
-
Immunoglobulin
- mAbs:
-
Monoclonal antibodies
- MBL:
-
Mannan binding lectin
- MR:
-
Mannose receptor
- SpA:
-
Staphylococcal protein A
- SpG:
-
Streptococcal protein G
- VH :
-
Variable heavy chain
- VL :
-
Variable light chain
References
Alzari PM, Lascombe MB, Poljak RJ (1988) Three-dimensional structure of antibodies. Annu Rev Immunol 6:555–580
Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, Mckelvey T, Li Y, Drummond J, Prueksaritanont T, Vlasak J (2009) Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. Mol Immunol 46:1878–1882
Burton DR (1985) Immunoglobulin G: functional sites. Mol Immunol 22:161–206
Burton DR, Woof JM (1992) Human antibody effector function. Adv Immunol 51:1–84
Coloma MJ, Trinh RK, Martinez AR, Morrison SL (1999) Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1→6) dextran antibody. J Immunol 162:2162–2170
Davies DR, Metzger H (1983) Structural basis of antibody function. Annu Rev Immunol 1:87–117
Harris LJ, Larson SB, Hasel KW, Mcpherson A (1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36:1581–1597
Harris LJ, Skaletsky E, Mcpherson A (1998) Crystallographic structure of an intact IgG1 monoclonal antibody. J Mol Biol 275:861–872
Huang L, Lu J, Wroblewski VJ, Beals JM, Riggin RM (2005) In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. Anal Chem 77:1432–1439
Kato M, Mochizuki K, Hashizume S, Tachibana H, Shirahata S, Murakami H (1993) Activity enhancement of a lung cancer-associated human monoclonal antibody HB4C5 by N-deglycosylation. Hum Antibodies Hybridomas 4:9–14
Khurana S, Raghunathan V, Salunke DM (1997) The variable domain glycosylation in a monoclonal antibody specific to GnRh modulates antigen binding. Biochem Biophys Res Commun 234:465–469
Liu H, May K (2012) Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. mAbs 4:17–23
Liu D, Ren D, Huang H, Dankberg J, Rosenfeld R, Cocco MJ, Li L, Brems DN, Remmele RL Jr (2008) Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry 47:5088–5100
Liu YD, Van Enk JZ, Flynn GC (2009) Human antibody Fc deamidation in vivo. Biologicals 37:313–322
Mimura Y, Ashton PR, Takahashi N, Harvey DJ, Jefferis R (2007) Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J Immunol Methods 326:116–126
Nose M, Wigzell H (1983) Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A 80:6632–6636
Padlan EA, Segal DM, Spande TF, Davies DR, Rudikoff S, Potter M (1973) Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol 245:165–167
Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G (2009) Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci 18:424–433
Pound JD, Lund J, Jefferis R (1993) Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst. Mol Immunol 30:233–241
Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD (2001) The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 276:16469–16477
Redpath S, Michaelsen TE, Sandlie I, Clark MR (1998) The influence of the hinge region length in binding of human IgG to human Fcgamma receptors. Hum Immunol 59:720–727
Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA (2001) Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293:1155–1159
Satoh M, Iida S, Shitara K (2006) Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin Biol Ther 6:1161–1173
Scallon BJ, Tam SH, Mccarthy SG, Cai AN, Raju TS (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524–1534
Segal DM, Padlan EA, Cohen GH, Rudikoff S, Potter M, Davies DR (1974) The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A 71:4298–4302
Smith MA, Easton M, Everett P, Lewis G, Payne M, Riveros-Moreno V, Allen G (1996) Specific cleavage of immunoglobulin G by copper ions. Int J Pept Protein Res 48:48–55
Sondermann P, Huber R, Oosthuizen V, Jacob U (2000) The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406:267–273
Tachibana H, Seki K, Murakami H (1993) Identification of hybrid-type carbohydrate chains on the light chain of human monoclonal antibody specific to lung adenocarcinoma. Biochim Biophys Acta 1182:257–263
Terry WD, Matthews BW, Davies DR (1968) Crystallographic studies of a human immunoglobulin. Nature 220:239–241
Voynov V, Chennamsetty N, Kayser V, Helk B, Forrer K, Zhang H, Fritsch C, Heine H, Trout BL (2009) Dynamic fluctuations of protein-carbohydrate interactions promote protein aggregation. PLoS One 4:E8425
Wallick SC, Kabat EA, Morrison SL (1988) Glycosylation of a VH residue of a monoclonal antibody against alpha (1-6) dextran increases its affinity for antigen. J Exp Med 168:1099–1109
Wang X, Kumar S, Singh SK (2011) Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations. Pharm Res 28:3128–3144
Wei Z, Feng J, Lin HY, Mullapudi S, Bishop E, Tous GI, Casas-Finet J, Hakki F, Strouse R, Schenerman MA (2007) Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. Anal Chem 79:2797–2805
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Moorthy, B.S. et al. (2015). Structure of Monoclonal Antibodies. In: Rosenberg, A., Demeule, B. (eds) Biobetters. AAPS Advances in the Pharmaceutical Sciences Series, vol 19. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2543-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2543-8_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2542-1
Online ISBN: 978-1-4939-2543-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)